Cyngn Inc. (CYN) · Oct 15, 2026 · Delisting
Nasdaq deficiency — Below $1.00 for 30 consecutive business days; 180-day cure window
Cyngn’s Nasdaq deficiency puts its $1 bid-price compliance at risk, giving the company until April 12, 2027 to cure the problem.
Cyngn is trying to commercialize autonomous-driving software and industrial vehicles through its DriveMod and Enterprise Autonomy Suite products, while still operating from a financially constrained position; its latest quarterly filing showed approximately $2.2 million of unrestricted cash and $37.5 million of short-term investments as of June 30, 2026.
The filing adds a real listing risk to that commercialization effort. Nasdaq says Cyngn failed the $1.00 minimum bid-price rule after its stock closed below that level for 30 straight business days.
This is not an immediate delisting, but it creates a deadline the company must actively solve. Cyngn has until April 12, 2027 to regain compliance, generally by closing at or above $1.00 for at least 10 consecutive business days. 〔0〕
The likely strategic lever is a reverse split if the share price does not recover organically. Nasdaq may grant another 180-day period if Cyngn meets the other listing standards and commits to a reverse split if necessary; otherwise, the company could face a delisting determination and appeal process. 〔1〕
Bottom line: This does not interrupt Cyngn’s autonomous-vehicle rollout today, but it adds a material capital-markets constraint and raises the possibility of a reverse split or eventual delisting if the company cannot sustain a compliant share price. 〔2〕
Nasdaq cure deadline, April 12, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!